Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,247,245,654
+$39,098,999 QoQ
Shares Held
4,910,996
-0.6% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#56
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $6,826,194,566 across 15 Drug Manufacturers - General names. JNJ ranks #2 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,175,866 | $1,410,369,073 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
4,910,996 | $1,247,245,654 | |
| 3 | ABBV |
AbbVie Inc.
|
4,886,670 | $1,229,681,638 | |
| 4 | AMGN |
Amgen Inc
|
1,689,843 | $611,925,947 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,996,890 | $513,600,365 | |
| 6 | AZN |
Astrazeneca PLC
|
2,281,431 | $432,604,946 | |
| 7 | NVS |
Novartis AG
|
2,330,979 | $365,311,028 | |
| 8 | PFE |
Pfizer Inc
|
9,513,242 | $229,078,867 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,247,245,654 | 4,910,996 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,208,146,655 | 4,942,508 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $943,525,819 | 4,559,197 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $952,201,788 | 5,135,378 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $751,613,707 | 4,920,548 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $781,305,905 | 4,711,203 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $656,960,646 | 4,542,668 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $715,380,485 | 4,414,294 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $626,053,997 | 4,283,347 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $660,310,844 | 4,174,163 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $622,035,229 | 3,968,580 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $616,369,566 | 3,957,429 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $535,946,642 | 3,237,957 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $681,175,090 | 4,394,678 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $583,456,931 | 3,302,898 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $512,230,309 | 3,135,592 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $519,593,781 | 2,927,124 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $484,396,528 | 2,733,152 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $457,203,563 | 2,672,611 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $407,941,571 | 2,525,954 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $399,721,676 | 2,426,379 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $375,351,404 | 2,283,854 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $272,594,593 | 1,732,079 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $250,335,913 | 1,681,461 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $231,409,477 | 1,645,520 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $199,580,515 | 1,522,005 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||